I read with interest the article by Jensen et al. (JVDI 27(5) :576-580) in which the authors examined the predictive value of Canine distemper virus (CDV) neutralizing antibody titer on protection against experimental infection. The authors found that all 4 dogs with antibody titers ≥16 were protected and all 5 vaccinated dogs with titers <16 were also protected. They concluded that the positive predictive value of antibody titers was 100%, while the negative predictive value was 0%. Attribution of a negative predictive value of 0% was based on the fact that all 5 vaccinated dogs with titers <16 ("suggesting susceptibility," according to the authors) were still protected. There is an alternate explanation for their findings. First, it would be useful to know if the 16-titer cutoff value was based on the actual dilution of the serum used in the test or the final dilution after virus is added to the test. If the latter is applicable, it would mean that their cutoff value was actually 32. Second, although "protective" cutoff titer values of 16 and 32 have been widely used in the literature, there appears to be no published experimental data to support those values. In fact, unpublished observations from this writer suggest that neutralizing antibody titers as low as 4 may be protective. The authors generated data that could be used to support another cutoff value. Accordingly, I would like to suggest that the authors reanalyze the available titer data using cutoff values of 4, 8, and 16, with the titer being defined as the reciprocal of the final dilution of serum after virus is added to the test. Such analysis could provide experimental evidence to support the possibility that all titers ≥4 may be protective against CDV.
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Authors' response
The authors thank Dr. Saliki for his critical reading and insightful questions and suggestions. As previously stated by one of the authors, 1 we believe that the actual titer of antibody in vaccinated dogs is not of importance to indicate protection, as long as virus-specific antibodies are detectable. In fact, unpublished observations from one of the authors (Schultz) suggest that titers of 2 are protective in vaccinated dogs but not in passively immunized dogs. Because of some of the unvaccinated dogs having prechallenge CDV virus neutralization (VN) titers that were positive at ≤16, the authors were in agreement with the laboratory that CDV VN results must be >16 to be considered a true positive. Use of a lower cutoff value would require an assay with greater specificity at higher serum concentrations. As to whether the CDV VN results were based on the serum dilution or final assay dilution, this information would be very relevant if comparing results from different laboratories. However, because the CDV VN results described in the study were obtained from the same laboratory, this does not alter our conclusion that detection of CDV-specific antibodies is predictive of whether dogs are resistant to challenge with virulent CDV.
Wayne A. Jensen Professor and Interim Head, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 
